Ebola
Scientists develop treatment for all strains of Ebola
January 10, 2019Research and Development Ebola, primates, research UTMB, texas, zmapp
Scientists at the University of Texas Medical Branch (UTMB) in Galveston, Texas have developed a new experimental drug that protects …
Ebola outbreak in Congo may last another 6 months, WHO officials say
November 14, 2018Research and Development Congo, Ebola, WHO, health, infectious diseases
The outbreak of Ebola in the Democratic Republic of Congo (DRC) is expected to last until mid-2019, a World Health …
MSD’s experimental vaccine to be used in fight against Congo Ebola outbreak
August 8, 2018Research and Development Congo, Ebola, MSD, Merck, Vaccine, pharma
MSD’s experimental drug rVSV-ZEBOV will be used in tackling the latest Ebola outbreak in the Democratic Republic of Congo, after …
The June 2018 issue of Pharmafocus is now live!
May 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ebola, GDPR, Trump, UK, brexit, data managment, market access, pharma
The new June edition of Pharmafocus is now available to read online.
Ebola threat intensifies in DR Congo
May 18, 2018Medical Communications Ebola, MSD, biotech, drugs, pharma, pharmaceutical
The Ebola outbreak in the Democratic Republic of Congo is becoming increasingly serious, after it was confirmed that there was …
Trials reveal two strong vaccine candidates for Ebola
October 16, 2017Research and Development, Sales and Marketing Ebola, biotech, drugs, pharma, pharmaceutical
Two clinical-stage vaccine candidates for Ebola have produced stunning results, not least because an unexpected protection emerged. The two therapies …
GSK proposes biopreparedness unit to combat global outbreaks
September 9, 2016Medical Communications, Research and Development Ebola, GSK, Zika
London-based pharma giant GlaxoSmithKline has proposed the creation of a biopreparedness unit to help avert crises like those we have …
MSD and GAVI agree Ebola vaccine deal
January 20, 2016Manufacturing and Production, Research and Development Ebola, GAVI, MSD, WHO
MSD and the global vaccine alliance Gavi have agreed a deal to provide 300,000 dosesof an Ebola virus vaccine, to …
China’s Tianjin invests $300m in Ebola plant
October 20, 2015Manufacturing and Production China, Ebola, Ebola vaccine, manufacturing, production, vaccines
China’s Tianjin CanSino Biotechnology, a developer of affordable vaccines, says that it will invest 2 billion Yuan (£203.3 million) in …
Researchers hopeful experimental antiviral treatment stops Ebola
August 26, 2015Research and Development Ebola, Ebola virus, Ebola virus disease, Toyama Chemical, VSV-ZEBOV, favipiravir, zmapp
An experimental antiviral therapy may have prevented British healthcare workers from contracting Ebola after exposure to the disease in West …
Encouraging first results from trial of Merck’s Ebola vaccine
July 31, 2015Research and Development, Sales and Marketing Africa, EBV, Ebola, Ebola virus, Ebola virus disease, Vaccine, WHO, World Health Organisation, guinea, vaccination
The first trial of an experimental Ebola vaccine suggests it provides high protection against the disease as early as ten …
Merck Ebola vaccine safe and effective in latest trials
April 2, 2015Research and Development, Sales and Marketing Ebola, Merck, National Institutes of Health, VSV-ZEBOV, Vaccine, Walter Reed Army Institute of Research, newlink
Merck and NewLink’s experimental Ebola vaccine has been found to be safe and effective in a new trial in the …
Merck and NewLink Ebola vaccine trial begins
March 6, 2015Sales and Marketing Ebola, Merck, Vaccine, WHO, newlink, rVSV-EBOV
Merck and US-based biopharma firm NewLink Genetics’ investigational Ebola vaccine is being used in Phase III trials in West Africa. …
ZMapp trials start in Liberia
March 2, 2015Research and Development, Sales and Marketing Africa, Ebola, Mapp, Vaccine, liberia, zmapp
Clinical trials to test the safety and efficacy of the experimental Ebola vaccine ZMapp are underway in infected parts of …
Scientists warn Ebola virus is mutating
January 29, 2015Research and Development, Sales and Marketing Africa, Ebola, GAVI, GSK, Institut Pasteur, J&J, JJ, guinea
Researchers in France studying the Ebola epidemic say the virus has mutated making it potentially even more contagious. Scientists based …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
